Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

New Rutgers Graduate Program Trains Students to Meet Changing Health Care Demands

New Brunswick, NJ, September 15, 2014 ― Rutgers, The State University of New Jersey is now offering a Master of Science Degree in Health Outcomes, Policy and Economics.

The new joint-degree program — conceived by Christopher Molloy, Rutgers senior vice president of research and economic development and the former dean of the Ernest Mario School of Pharmacy at Rutgers — brings together the Rutgers schools of Pharmacy and Public Health.

Even before the Affordable Health Care Act became law, Molloy, who had a career in the pharmaceutical industry before coming to Rutgers in 2007, believed that there would be a continued need for trained health care professionals who could look at the research and measure the therapeutic and economic benefits of health care treatments and drug therapies.

Kimberly McGuigan, the executive director of the program who joined Rutgers last year, said the new graduate program will focus on health economics, epidemiology, biostatistics and U.S. health care policy.

A goal of the program is to teach students how to evaluate biomedical research and economic models to try to improve health care decisions that need to be made by patients, health care providers and payers.

As part of the program, she said, students will have the opportunity to be mentored by a senior executive or researcher in the private health care sector – providing them with broader insight into how scientific evidence is used to evaluate innovations in health care delivery and financing.

For the complete story, click here.